Literature DB >> 11728000

Applications of yeast in drug discovery.

D Ma1.   

Abstract

The yeast Saccharomyces cerevisiae is perhaps the best-studied eukaryotic organism. Its experimental tractability, combined with the remarkable conservation of gene function throughout evolution, makes yeast the ideal model genetic organism. Yeast is a non-pathogenic model of fungal pathogens used to identify antifungal targets suitable for drug development and to elucidate mechanisms of action of antifungal agents. As a model of fundamental cellular processes and metabolic pathways of the human, yeast has improved our understanding and facilitated the molecular analysis of many disease genes. The completion of the Saccharomyces genome sequence helped launch the post-genomic era, focusing on functional analyses of whole genomes. Yeast paved the way for the systematic analysis of large and complex genomes by serving as a test bed for novel experimental approaches and technologies, tools that are fast becoming the standard in drug discovery research

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728000     DOI: 10.1007/978-3-0348-8308-5_3

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  4 in total

1.  Quantitative Gene Expression of ERG9 in Model Saccharomyces cerevisiae: Chamomile Extract For Human Cancer Treatment.

Authors:  Maryam Hosseinpour; Mohsen Mobini-Dehkordi; Hossein Teimori
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease.

Authors:  Juan Garrido-Maraver; Mario D Cordero; Irene Domínguez Moñino; Sheila Pereira-Arenas; Ana V Lechuga-Vieco; David Cotán; Mario De la Mata; Manuel Oropesa-Ávila; Manuel De Miguel; Juan Bautista Lorite; Eloy Rivas Infante; Manuel Alvarez-Dolado; Plácido Navas; Sandra Jackson; Silvia Francisci; José A Sánchez-Alcázar
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches.

Authors:  Sebastian Hofer; Katharina Kainz; Andreas Zimmermann; Maria A Bauer; Tobias Pendl; Michael Poglitsch; Frank Madeo; Didac Carmona-Gutierrez
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 6.261

4.  The effect of bioactive compounds on in vitro and in vivo antioxidant activity of different berry juices.

Authors:  Ana Slatnar; Jerneja Jakopic; Franci Stampar; Robert Veberic; Polona Jamnik
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.